These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Targeted therapeutic applications of acoustically active microspheres in the microcirculation. Chappell JC; Price RJ Microcirculation; 2006 Jan; 13(1):57-70. PubMed ID: 16393947 [TBL] [Abstract][Full Text] [Related]
24. Characterization of Contrast Agent Microbubbles for Ultrasound Imaging and Therapy Research. Mulvana H; Browning RJ; Luan Y; de Jong N; Tang MX; Eckersley RJ; Stride E IEEE Trans Ultrason Ferroelectr Freq Control; 2017 Jan; 64(1):232-251. PubMed ID: 27810805 [TBL] [Abstract][Full Text] [Related]
25. [Key problems in using ultrasonic cavitating bubble as a gene or drug vector]. Zhang Y; Chen T; Lin S Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Oct; 26(5):1129-32. PubMed ID: 19947504 [TBL] [Abstract][Full Text] [Related]
32. Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. Fujii H; Li SH; Wu J; Miyagi Y; Yau TM; Rakowski H; Egashira K; Guo J; Weisel RD; Li RK Eur Heart J; 2011 Aug; 32(16):2075-84. PubMed ID: 21196445 [TBL] [Abstract][Full Text] [Related]
33. Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart--gene therapy. Markkanen JE; Rissanen TT; Kivelä A; Ylä-Herttuala S Cardiovasc Res; 2005 Feb; 65(3):656-64. PubMed ID: 15664392 [TBL] [Abstract][Full Text] [Related]
34. Effect of low-frequency low-intensity ultrasound with microbubbles on prostate cancer hypoxia. Hou R; Xu Y; Lu Q; Zhang Y; Hu B Tumour Biol; 2017 Oct; 39(10):1010428317719275. PubMed ID: 28974155 [TBL] [Abstract][Full Text] [Related]
35. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Leong-Poi H; Christiansen J; Heppner P; Lewis CW; Klibanov AL; Kaul S; Lindner JR Circulation; 2005 Jun; 111(24):3248-54. PubMed ID: 15956135 [TBL] [Abstract][Full Text] [Related]
36. Targeted microbubbles in the experimental and clinical setting. Alzaraa A; Gravante G; Chung WY; Al-Leswas D; Bruno M; Dennison AR; Lloyd DM Am J Surg; 2012 Sep; 204(3):355-66. PubMed ID: 22920405 [TBL] [Abstract][Full Text] [Related]
37. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts. Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775 [TBL] [Abstract][Full Text] [Related]
38. Targeted antiangiogenesis gene therapy using targeted cationic microbubbles conjugated with CD105 antibody compared with untargeted cationic and neutral microbubbles. Zhou Y; Gu H; Xu Y; Li F; Kuang S; Wang Z; Zhou X; Ma H; Li P; Zheng Y; Ran H; Jian J; Zhao Y; Song W; Wang Q; Wang D Theranostics; 2015; 5(4):399-417. PubMed ID: 25699099 [TBL] [Abstract][Full Text] [Related]
39. Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia. Oda S; Nagahama R; Nakano K; Matoba T; Kubo M; Sunagawa K; Tominaga R; Egashira K J Vasc Surg; 2010 Aug; 52(2):412-20. PubMed ID: 20573471 [TBL] [Abstract][Full Text] [Related]
40. Ultrasound, microbubbles and the blood-brain barrier. Meairs S; Alonso A Prog Biophys Mol Biol; 2007; 93(1-3):354-62. PubMed ID: 16959303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]